The Joint United Nations Programme on HIV/AIDS (UNAIDS) has welcomed the new targets set by world leaders at the United Nations General Assembly High Level Meeting on AIDS held in New York. Countries agreed to advance efforts towards reducing sexual transmission of HIV and halving by 2015 HIV infection among people who inject drugs. They also agreed to push towards eliminating new HIV infections among children in the next five years....
More »SEARCH RESULT
Total Matching Records found : 2547
Battle over the Anti-Violence Bill by John Dayal
Victims have not forgotten the following brutal tragedies in the life of independent India, even if the State and political parties may pretend to have. 1984—Delhi: On October 31, Prime Minister Indira Gandhi was assassinated by her two Sikh bodyguards in revenge for ‘Operation Bluestar’. For the next three days, as Doordarshan telecast the lying in state of her body, over 3000 Sikhs—men and boys—were burnt alive while policemen, politicians and...
More »Breaking a cultural taboo by Maitreyee Handique
Women speak out fears of resisting deep-seated taboos associated with menstruation, viewed even today as polluting in much of India The status of women in India, despite all the brave talk, remains as precarious as ever. This is, after all, a culture which not just condones, but actively encourages the termination of foetuses determined to be female. Other crimes of violence against women are routine. Can things ever change? We took...
More »Rich Nations Wage Assault on Generic AIDS Drugs by Elizabeth Whitman
Moves by developed nations such as the United States to tighten intellectual property laws are threatening to limit production and distribution of generic drugs, which experts say have been and will remain key in the prevention and treatment of HIV/AIDS and currently account for 80 percent of HIV/AIDS treatment. These efforts are taking shape in two spheres. The first is in discussions on the outcome document that member states are expected...
More »Clinical trials claimed 25 lives in 2010, only 5 paid compensation by Kounteya Sinha
Rs 3 lakh – that's the price a pharmaceutical company has paid to the family of a person who died in their clinical trial. Others weren't even this lucky. According to the Drug Controller General of India's (DCGI) records, 25 people died in clinical trials carried out by nine pharmaceutical companies in 2010. Families of five of these victims received "compensation for trial related death" — the amount ranging from Rs...
More »
